Gene expression of apolipoprotein(a) within the wall of human aorta and carotid arteries

Atherosclerosis

Volumn 158, Issue 2, 2001, Pages 303-311

  Fu, Li ^a   Jamieson, Dara G ^a   Usher, David C ^b   Lavi, Ehud ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF DELAWARE   (United States)

^c University of Delaware ^*  (United States)

Author keywords

Aorta; Apolipoprotein (a); Apolipoprotein B; Atherosclerosis; Blood vessels; Carotid artery; cDNA sequencing; Immunohistochemistry; Lipoprotein (a); RT PCR

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; MESSENGER RNA;

ADOLESCENT; ADULT; AGED; AORTA WALL; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; AUTOPSY; CAROTID ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEMORAL VEIN; GENE EXPRESSION; GENETIC TRANSCRIPTION; HOUSEKEEPING GENE; HUMAN; HUMAN TISSUE; INFANT; LIVER; MALE; MOLECULAR CLONING; NEWBORN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; SOUTHERN BLOTTING; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; AORTA; APOLIPOPROTEINS; APOLIPOPROTEINS B; APOPROTEIN(A); ARTERIOSCLEROSIS; BLOTTING, SOUTHERN; CAROTID ARTERIES; CHILD; FEMALE; GENE EXPRESSION; HUMANS; LIPOPROTEIN(A); LIVER; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0034808665     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00443-9     Document Type: Article

References (51)

1. The mysteries of lipoprotein(a)
2. Lipoprotein(a): Structural implications for pathophysiology
3. How often has Lp(a) evolved?
4. Lipoproteins and cardiovascular risk-from genetics to CHD prevention
5. Lipoprotein(a) and coronary heart disease: A prospective case-control study in a general population sample of middle-aged men
6. A prospective study of lipoprotein(a) and the risk of myocardial infarction
7. Association of levels of lipoprotein(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography
8. Lipoprotein Lp(a). A risk factor for myocardial infarction
9. Lipoprotein(a) levels and risk of coronary heart disease in men
10. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen
11. Further characterization of cellular plasminogen binding site: Evidence that plasminogen 2 and lipoprotein a compete for the same site
12. A potential basis for the thrombotic risks associated with lipoprotein(a)
13. Lipoprotein (a) modulation of endothelial celll surface fibrinolysis and its potential role in atherosclerosis
14. Plasma lipoproteins: Teaching old dogmas new tricks
15. Lp(a): An interloper in the fibrinolytic system?
16. Proliferation of human smooth muscle cells promoted by lipoprotein (a)
17. Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice
18. Lipoprotein (a) in the arterial wall
19. Lipoprotein (a) in the arterial wall
20. Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients
21. Morphological detection and quantification of lipoprotein(a) deposition in atheromatous lesions
22. Quantitation and localization of apolipoproteins(a) and B in coronary artery bypass vein grafts resected at re-operation
23. Quantification of apo(a) and apoB in human atherosclerotic lesions
24. Morphological co-localisation of apolipoprotein(a) and fibrin in human coronary atheromas
25. Morphological detection and quantification of lipoprotein(a) deposition in atheromatous lesions of human aorta and coronary arteries
26. Apolipoprotein(a) deposition in atherosclerotic plaques of cerebral vessels: A potential role for endothelial cells in lesion formation
27. Apolipoprotein(a) deposition in atherosclerotic plaques of cerebral vessels and arteriolosclerotic parenchymal vessels
28. Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion
29. Human apolipoprotein B cDNA clone isolation and demonstration that liver apolipoprotein B mRNA is 22 kilobase in length
30. Apolipoprotein (a) gene accounts for greater than 90-percent of the variation in plasma lipoprotein (a) concentrations
31. Dietary fish oil lowers lipoprotein (a) in primary hypertriglyceridemia
32. Fish intake, independent of apo(a) size, accounts for lower plasma lipoprotein(a) levels in Bantu fisherman of Tanzania: The Lugalawa study
33. Effects of postmenopausal hormone replacement therapy on lipoproteins including lipoprotein(a) and LDL subfractions
34. A comparison of Lp(a) levels in fresh and frozen plasma using ELISAs with either anti-apo(a) or anti-apoB reporting antibodies
35. Effects of dietary fat saturation on plasma lipoprotein(a) and hepatic apolipoprotein(a) mRNA concentrations in cynomolgus monkeys
36. DNA sequencing with chain-terminating inhibitors
37. Rhesus monkey apolipoprotein(a): Sequence, evolution, and sites of synthesis
38. Multiple novel transcripts for apolipoprotein(a)-related gene II generated by alternative splicing in tissue- and cell type-specific manners
39. Both apolipoproteins B-48 and B-100 are synthesized and secreted by the human intestine
40. The human apolipoprotein(a)/plasminogen gene cluster contains a novel homologue transcribed in liver
41. Loss of a splice donor site at a 'Skipped exon' in a gene homologous to apolipoprotein(a) leads to an mRNA encoding a protein consisiting of a single kringle domain
42. Lipoprotein(a): Heterogeneity and biological relevance
43. Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease
44. Relative contributions of apolipoprotein(a) and apolipoprotein-B to the development of fatty lesions in the proximal aorta of mice
45. Apolipoproteins B, (a), and E, accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis
46. Extraction of lipoprotein(a), apoB, and apoE from fresh huamn arterial wall and atherosclerotic plaques
47. Lipoprotein(a) and atherosclerosis
48. Lipoprotein(a) in heart disease
49. Lipoprotein(a) enhances the expression of intercellular adhesion molecule-1 in cultured human umbilical vein endothelial cells
50. Defensin stimulates the binding of Lp(a) to human vascular endothelial and smooth muscle cells
51. Dominant negative effect of TGF-beta 1 and TNF-alpha on basal and IL-6-induced lipoprotein(a) and apolipoprotein(a) mRNA expression in primary monkey hepatocyte cultures